GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » European Biotech Acquisition Corp (NAS:EBACU) » Definitions » Pre-Tax Income

EBACU (European Biotech Acquisition) Pre-Tax Income : $0.34 Mil (TTM As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is European Biotech Acquisition Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. European Biotech Acquisition's pretax income for the three months ended in Dec. 2022 was $-0.97 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2022 was $0.34 Mil. European Biotech Acquisition's pretax margin was %.

European Biotech Acquisition Pre-Tax Income Historical Data

The historical data trend for European Biotech Acquisition's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Biotech Acquisition Pre-Tax Income Chart

European Biotech Acquisition Annual Data
Trend Dec21 Dec22
Pre-Tax Income
1.48 0.34

European Biotech Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Pre-Tax Income Get a 7-Day Free Trial -0.45 1.51 0.20 -0.40 -0.97

Competitive Comparison of European Biotech Acquisition's Pre-Tax Income

For the Shell Companies subindustry, European Biotech Acquisition's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Biotech Acquisition's Pre-Tax Income Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, European Biotech Acquisition's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where European Biotech Acquisition's Pre-Tax Income falls into.


;
;

European Biotech Acquisition Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

European Biotech Acquisition's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.818+3.161+0+0+5.5511151231258E-17
=0.34

European Biotech Acquisition's Pretax Income for the quarter that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.167+0.198+0+0+1.1102230246252E-16
=-0.97

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Biotech Acquisition  (NAS:EBACU) Pre-Tax Income Explanation

European Biotech Acquisition's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.969/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Biotech Acquisition Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of European Biotech Acquisition's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

European Biotech Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » European Biotech Acquisition Corp (NAS:EBACU) » Definitions » Pre-Tax Income
Comparable Companies
CNTQ LION MEOA SCMA LATG NBST CCTS FRBN NMMC DMAQ GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
EPFL Innovation Park Building, Lausanne, CHE, 1015
Website
https://www.lspvc.com
European Biotech Acquisition Corp is a blank check company.
Executives
Mohammad Sohail Fazeli director JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Martijn Kleijwegt director JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Volkert H. Doeksen director RIOUWSTRAAT 10, THE HAGVE P7 2585HA
Fernandez De Araoz Eduardo Bravo officer: Chief Executive Officer JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Koen Sintnicolaas officer: Chief Financial Officer JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Lsp Sponsor Ebac B.v. 10 percent owner JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Van De Stolpe Onno director JOHANNES VERMEERPLEIN 9, AMSTERDAM, P7 1071 DV
Marcus Antonius Wegter director JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV
Lsp Management Group B.v. 10 percent owner JOHANNES VERMEERPLEIN 9, AMSTERDAM P7 1071 DV